1-15 of 15
Matthew Schwede
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial

Free
Kelly Bolton, Yazan Madanat, Namrata Chandhok, David Sallman, Abhay Singh, Kiran Vij, Jane Churpek, Luke Fletcher, Matthew Schwede, Curtis Lachowiez, Amber Afzal, Rickey Myhand, Alejandro Marinos Velarde, Rosalyn Marar, Tibor Kovacsovics, Hannah Mitchell, Maria Stoentcheva, Kimberly Johansson, Giulia Petrone, Kyra Ddungu, John Cole, Hannah Hartman, Ryan Monahan, Karen Vandervort, Mrinal Patnaik, Akriti Jain, Matthew Walter, Yael Kusne, Alexander Coltoff, Hetty Carraway, Jennifer Yannucci, Tian Zhang, Stephen Chung, Geoffrey Uy, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 635.
https://doi.org/10.1182/blood-2025-635
Published: 2025
Journal Articles

Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)

Free
Matthew Frank, David Qualls, Armin Ghobadi, Jordan Gauthier, Michael Tees, Luke Mountjoy, Joseph McGuirk, Sattva Neelapu, Reem Karmali, Iris Isufi, Brian Hill, Craig Sauter, Catherine Diefenbach, Jay Spiegel, Lizamarie Bachier-Rodriguez, Monalisa Ghosh, Nirav Shah, Rahul Lakhotia, Francisco Hernandez-Ilizaliturri, Anuja Abhyankar, Elise Chong, Matthew Schwede, Krish Patel, Olalekan Oluwole, John Baird, Nathan Denlinger, Farrukh Awan, Michael Jain, John Timmerman, Cesar Sanchez, Muthu Kumaran, Jean Yared, Jon Arnason, Ishan Tatake, Usama Gergis, Peter Riedell, Keith Pratz, Nirali Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 667.
https://doi.org/10.1182/blood-2025-667
Published: 2025
Journal Articles

Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Agrima Mian, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 402.
https://doi.org/10.1182/blood-2025-402
Published: 2025
Journal Articles

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Free
XI Yang, Yasmin Karimi, Xiaoying Chen, Adrienne Nedved, Yucai Wang, Natalie Grover, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Justin Kline, Alyssa Gibson, Javier Munoz, Raja Prince-Eladnani, Rodolfo Garza Morales, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill, Taylor Brooks
Journal: Blood
Blood (2025) 146 (Supplement 1): 401.
https://doi.org/10.1182/blood-2025-401
Published: 2025
Journal Articles

IDH1/2-mutant clonal hematopoiesis: A novel driver of autoinflammatory disease

Free
Griffen Mustion, Flore Castellan, John Cole, Mei-Kay Wong, Kimberly Johansson, Scott Goldberg, Yazan Madanat, Namrata Chandhok, Abhay Singh, David Sallman, Jane Churpek, Curtis Lachowiez, Jennifer Yannucci, Luke Fletcher, Matthew Schwede, Amber Afzal, Yael Kusne, Alejandro Marinos Velarde, Alexander Coltoff, Rickey Myhand, Akriti Jain, Kiran Vij, Rosalyn Marar, Hannah Mitchell, Maria Stoentcheva, Giulia Petrone, Kyra Ddungu, Hannah Hartman, Ryan Monahan, Karen Vandervort, Tibor Kovacsovics, Hetty Carraway, Tian Zhang, Stephen Chung, Geoffrey Uy, Eytan Stein, Devendra Hiwase, Matthew Walter, Mrinal Patnaik, David Beck, Kelly Bolton
Journal: Blood
Blood (2025) 146 (Supplement 1): 3169.
https://doi.org/10.1182/blood-2025-3169
Published: 2025
Journal Articles

Twelve month landmark analysis of outcomes of relapsed or refractory large B-cell lymphoma patients achieving prolonged remission with glofitamab or epcoritamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 4499.
https://doi.org/10.1182/blood-2025-4499
Published: 2025
Journal Articles

Patients with TP53-mutated AML/MDS without complex or monosomal karyotype can achieve durable survival benefits with allogeneic HCT

Free
Nikeshan Jeyakumar, Nancy Torres, Suneeta Godbole, Fiona Yamamoto, Bing Zhang, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hany Elmariah, Matthew Frank, Hitomi Hosoya, Laura Johnston, Everett Meyer, Lekha Mikkilineni, Robert Lowsky, Robert Negrin, Andrew Rezvani, Judith Shizuru, Surbhi Sidana, Melody Smith, Wen-Kai Weng, David Miklos, Matthew Schwede, Gabriel Mannis, Tian Zhang, Lori Muffly, Vanessa Kennedy
Journal: Blood
Blood (2025) 146 (Supplement 1): 2525.
https://doi.org/10.1182/blood-2025-2525
Published: 2025
Journal Articles

Circulating Tumor DNA (ctDNA) Enables Superior and Universal Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) Highly Predictive of Relapse Free and Overall Survival

Free
Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Sky Kim, Kailee Tanaka, Sanjeeth Rajaram, Mia Carleton, Raymond Yin, Matthew Alkaitis, Matthew Schwede, Brian J. Sworder, Michael S. Khodadoust, Ravi Majeti, David Kurtz, Tian Y Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2024-201701
Published: 2024
Journal Articles

Investigational Cell Therapy Beyond Oncology: Education, Communication, and Lessons Learned from Utilizing a Centralized Oncology Based Cell Therapy Program

Free
Neil Bailey, Tenzin Tsomo, Jordan Briggs, Tori Braun, Krystle Pagarigan, Morgan Hanson, Phuong Nam Doan, Kory Barrow, Wezi Longwe, Rachael Crickman, Evonne Lackey, Swathi Namburi, Matthew Schwede, Krish Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 7956.
https://doi.org/10.1182/blood-2024-208076
Published: 2024
Journal Articles

Acute Myeloid Leukemia with Inv(3) or t(3;3): A Clinical and Cytogenetic Characterization of 40 Patients

Free
Maria Moscvin, Matthew Schwede, Gabriel Mannis, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4231.
https://doi.org/10.1182/blood-2023-186672
Published: 2023
Journal Articles

Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)

Free
Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Matthew Schwede, Kailee Tanaka, Matthew Alkaitis, Raymond Yin, Brian J. Sworder, Gabriel Mannis, Ravindra Majeti, Michael S. Khodadoust, David M. Kurtz, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4307.
https://doi.org/10.1182/blood-2023-181459
Published: 2023
Journal Articles

The Shifting Prognosis of FLT3 Mutations in Acute Myeloid Leukemia in the Era of Targeted Therapy: A Real-World Study Using Large-Scale Electronic Health Record Data

Free
Matthew Schwede, Gladys Rodriguez, Solomon Henry, Douglas Wood, Gabriel Mannis, Ravindra Majeti, Jonathan Chen, Eran Bendavid, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 958.
https://doi.org/10.1182/blood-2023-187725
Published: 2023
Journal Articles

Harnessing Artificial Intelligence for Risk Stratification in Acute Myeloid Leukemia (AML): Evaluating the Utility of Longitudinal Electronic Health Record (EHR) Data Via Graph Neural Networks

Free
Riya Sinha, Matthew Schwede, Ben Viggiano, David Kuo, Solomon Henry, Douglas Wood, Gabriel Mannis, Ravindra Majeti, Jonathan Chen, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 960.
https://doi.org/10.1182/blood-2023-190151
Published: 2023
Journal Articles

Analysis of Treatment Patterns and Outcomes in Patients Ages 60-74 in the Post-Venetoclax Era

Free
Emma C St. Martin, Matthew Schwede, Bita Fakhri, Jason Gotlib, Michaela Liedtke, William Shomali, Tian Y. Zhang, Gabriel Mannis
Journal: Blood
Blood (2023) 142 (Supplement 1): 1490.
https://doi.org/10.1182/blood-2023-190614
Published: 2023
Journal Articles

Heterogeneous Definitions of Secondary Acute Myeloid Leukemia (AML) Yield Distinct Outcomes in Response to First-Line Treatment with Hypomethylating Agents (HMA) and Venetoclax (Ven)

Free
Irena Tan, Matthew Schwede, Paul Phan, Raymond Yin, Tian Y Zhang, Gabriel N. Mannis
Journal: Blood
Blood (2021) 138 (Supplement 1): 1216.
https://doi.org/10.1182/blood-2021-147886
Published: 2021